NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc.（NBSE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
nbse · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2025年2月27日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.38
短期股价预测
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NBSE · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-10-21 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2022-10-18 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2022-10-17 | Chardan Capital | Downgrade ↓ | Buy→Neutral |
| 2022-08-12 | Chardan Capital | Maintains | Buy→Buy |
| 2022-05-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-05-13 | Chardan Capital | Maintains | Buy→Buy |
| 2021-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-02-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-06-16 | RBC Capital | Maintains | Outperform→Outperform |
| 2020-04-01 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on NeuBase Therapeutics, Inc. (NBSE) stock. Of the recent 16 rating actions, 0 were upgrades and 3 were downgrades. 6 analysts currently cover NBSE.
分析师推荐趋势
NBSE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$8M
EPS This Year
$-7.29
EPS Next Year
$-1.92
↓ 73.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast NBSE EPS of $-7.29 for the current fiscal year, based on estimates from 1 analysts. The NBSE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NBSE 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NBSE 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
NeuBase Therapeutics, Inc. 在 NASDAQ 上市，代码 NBSE。NBSE 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
NBSE 预测 · 8 个问题根据 6 位华尔街分析师，NBSE 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.38，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.